We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Forte Biosciences
FBRX
$1.12B
| $136K | ﹤0.01% |
30
-6
| -17% | -$27.8K |
|
|
EGOV
1602
DELISTED
NIC Inc
EGOV
| $136K | ﹤0.01% |
10,254
-1,284
| -11% | -$19K |
|
1603
Ardelyx
ARDX
$1.24B
| $133K | ﹤0.01% |
26,248
-4,322
| -14% | -$27K |
|
1604
Immunic
IMUX
$182M
| $133K | ﹤0.01% |
49
-8
| -14% | -$18.4K |
|
1605
Minerva Neurosciences
NERV
$188M
| $133K | ﹤0.01% |
2,660
-438
| -14% | -$21K |
|
|
CYS
1606
DELISTED
CYS Investments Inc.
CYS
| $133K | ﹤0.01% |
19,790
-3,192
| -14% | -$22K |
|
1607
Amkor Technology
AMKR
$16.1B
| $132K | ﹤0.01% |
13,028
-2,354
| -15% | -$24.5K |
|
1608
Gray Television
GTN
$407M
| $131K | ﹤0.01% |
+10,281
| New | +$155K |
|
|
DF
1609
DELISTED
Dean Foods Company
DF
| $131K | ﹤0.01% |
15,148
-6,942
| -31% | -$68.5K |
|
|
CMO
1610
DELISTED
Capstead Mortgage Corp.
CMO
| $131K | ﹤0.01% |
15,095
-1,992
| -12% | -$17.2K |
|
1611
Savara
SVRA
$1.13B
| $130K | ﹤0.01% |
14,102
-2,331
| -14% | -$27.4K |
|
1612
Helix Energy Solutions
HLX
$1.46B
| $129K | ﹤0.01% |
22,295
-2,810
| -11% | -$19.7K |
|
|
CALA
1613
DELISTED
Calithera Biosciences, Inc
CALA
| $128K | ﹤0.01% |
1,016
-167
| -14% | -$26K |
|
|
KND
1614
DELISTED
Kindred Healthcare
KND
| $128K | ﹤0.01% |
13,971
-1,832
| -12% | -$17K |
|
1615
Arbutus Biopharma
ABUS
$865M
| $127K | ﹤0.01% |
25,453
-4,207
| -14% | -$22.3K |
|
1616
MannKind Corp
MNKD
$1.28B
| $127K | ﹤0.01% |
55,699
-7,414
| -12% | -$20K |
|
|
CNSL
1617
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $126K | ﹤0.01% |
11,516
-5,278
| -31% | -$63.3K |
|
|
FIT
1618
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $126K | ﹤0.01% |
24,777
-3,996
| -14% | -$21.3K |
|
1619
Corvus Pharmaceuticals
CRVS
$1.1B
| $125K | ﹤0.01% |
10,804
-1,783
| -14% | -$16.9K |
|
|
TRST
1620
Trustco Bank Corp NY
TRST
$1B
| $125K | ﹤0.01% |
2,960
-368
| -11% | -$16.2K |
|
|
BLCM
1621
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $124K | ﹤0.01% |
1,885
-310
| -14% | -$23.4K |
|
1622
Independence Realty Trust
IRT
$3.92B
| $123K | ﹤0.01% |
13,357
-1,635
| -11% | -$14.8K |
|
1623
MiMedx Group
MDXG
$626M
| $114K | ﹤0.01% |
16,417
-2,076
| -11% | -$24.2K |
|
1624
Forum Energy Technologies
FET
$654M
| $113K | ﹤0.01% |
515
-83
| -14% | -$23.1K |
|
1625
Kratos Defense & Security Solutions
KTOS
$8.88B
| $113K | ﹤0.01% |
10,947
-1,764
| -14% | -$19.6K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.